在癌症免疫中代谢重新连接和通信
Nicole M Chapman1, Hongbo Chi1
1Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Cell chemical biology
|March 1, 2024
概括
通过了解瘤代谢如何影响免疫反应,可以改善癌症免疫疗法. 准代谢途径提供了一种新的策略,可以增强抗瘤免疫力并提高治疗效率.
科学领域:
- 免疫学 免疫学 免疫学
- 代谢途径 代谢途径
- 癌症生物学 癌症生物学
背景情况:
- 免疫系统在瘤的发展和进展中起着至关重要的作用.
- 免疫疗法已经彻底改变了癌症治疗,但在有效性方面面临局限性.
- 与新陈代谢相关的过程越来越被认为是抗瘤免疫力的关键调节者.
研究的目的:
- 总结细胞内代谢通路在瘤微环境中的免疫细胞功能中的作用.
- 讨论细胞间代谢通信如何影响抗瘤免疫和信号事件.
- 探索针对代谢途径的策略,以增强癌症免疫疗法.
主要方法:
- 审查关于细胞内代谢途径和免疫细胞功能现有的文献.
- 分析瘤微环境中的细胞间代谢通信.
- 讨论基于营养的干预措施和代谢向策略.
主要成果:
- 细胞内代谢重编程显著影响瘤中的免疫细胞功能.
- 细胞间代谢交叉和代谢物信号调节抗瘤免疫反应.
- 向瘤或免疫细胞中的代谢途径,或通过营养调节,显示出增强免疫疗法的希望.
结论:
- 瘤微环境中的代谢重编程和通信对于免疫反应至关重要.
- 向瘤和免疫细胞代谢为开发新型癌症免疫疗法提供了一个有希望的途径.
- 为了推进这些策略,需要对代谢活动概况和功能干扰进行进一步的研究.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cytotoxic T Cells-mediated Immune Response
908
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
908


